Tirzepatide

Tirzepatide is a synthetically produced research peptide that simultaneously targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Current research explores its impact on key metabolic pathways, with studies focusing on how it may influence glucose metabolism and energy regulation. CAS: 2023788-19-2
Appearance: Presented as a white to off-white lyophilised powder Reconstitution: Should be reconstituted using bacteriostatic water prior to use Storage: Unreconstituted product may be stored long-term (6 months to several years) at –20°C, or short-term at 2–8°C. Following reconstitution, store refrigerated at 2–8°C and use within 30 days.
Storage & Handling: Keep in a cool, dry environment away from direct light and moisture. All handling should follow standard laboratory safety protocols, including the use of appropriate personal protective equipment (PPE). Avoid skin, eye, and clothing contact at all times.
Disclaimer: All data is provided strictly for informational purposes and is derived from published scientific literature. This product is available exclusively for research use within the UK. Any use involving humans or animals is strictly prohibited and constitutes a violation of UK law.